Suggestions
Levi Garraway
Professional Background
Levi Garraway is a distinguished leader in the field of medicine and healthcare, recognized for his outstanding contributions to drug development and oncology research. Currently, he serves as the Executive Vice President, Head of Global Product Development and Chief Medical Officer at Genentech, a position that underscores his expertise in leading innovative medical strategies and product initiatives in biopharmaceuticals. His notable career includes influential roles with Roche, Eli Lilly and Company, and various prestigious academic institutions, emphasizing his dedication to advancing cancer treatment through both corporate and academic pathways.
In his current role at Genentech, Garraway spearheads global product development, focusing on bringing critical medications to market that address unmet medical needs for patients, particularly those affected by cancer. His strategic vision and leadership have been pivotal in fostering a culture of innovation and collaboration, enabling cross-functional teams to create impactful solutions in the pharmaceutical landscape.
Before his tenure at Genentech, Garraway excelled at Roche in the same capacity as Executive Vice President, where he further honed his ability to navigate complex clinical development pathways and regulatory requirements. His impact on the oncology landscape was solidified during his time as Senior Vice President at Eli Lilly, where he oversaw both research and development as well as global medical affairs for oncology—an experience that established him as a thought leader in the field.
Education and Achievements
Levi Garraway's academic pursuits laid a strong foundation for his illustrious career. He achieved significant educational milestones, earning both a Doctor of Medicine (M.D.) and a Doctor of Philosophy (Ph.D.) in Pharmacology and Chemistry from the prestigious Harvard Medical School. Garraway also holds a Bachelor of Arts degree from Harvard University, further evidencing his strong educational background in the sciences and liberal arts.
Throughout his career, Garraway has been recognized not only for his clinical insights but also for his commitment to integrating cutting-edge scientific research into therapeutic applications. As a former Associate Professor of Medicine at the Dana-Farber Cancer Institute, his work has been instrumental in advancing cancer research and therapy, enhancing the understanding of oncological processes, and contributing to groundbreaking discoveries in the field.
He was also a Senior Associate Member at the Broad Institute of MIT and Harvard, collaborating with some of the brightest minds in genomic medicine and playing a essential role in aligning research with clinical applications.
Notable Contributions and Achievements
In addition to his corporate leadership, Garraway has been an integral figure in the healthcare community, serving as a Founding Advisor for Foundation Medicine, an organization at the forefront of precision medicine. His advocacy for tailored treatment approaches in oncology reflects his deep understanding of the complex biology of cancer and the necessity of innovative solutions to improve patient outcomes.
His consulting experiences with organizations such as Novartis, alongside direct involvement in high-level strategic planning and medical affairs, have fortified his role as an asset in the pharmaceutical industry. Levi Garraway’s comprehensive expertise combines a rich blend of clinical acumen, research insight, and leadership in medical affairs, making him a key player in the quest for innovative cancer therapies.
Achievements
- Current Executive Vice President, Head of Global Product Development and Chief Medical Officer at Genentech.
- Former Executive VP, Head of Global Product Development and Chief Medical Officer at Roche.
- Previous Senior Vice President roles focused on Oncology Research and Development with Eli Lilly and Company.
- Founding Advisor at Foundation Medicine, contributing significantly to the advancement of precision medicine.
- Recognized academic with former positions as Associate Professor and Senior Associate Member at notable research institutions.
- Proven track record of spearheading successful cancer therapies from initial conception to market introduction.
